Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Pertussis toxin may contribute to hair loss in alopecia areata.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Gut bacteria may affect hair loss in people with celiac disease.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Key genes influencing sheep hair follicle development were identified, aiding wool breeding and understanding human hair conditions.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

Platelet-rich plasma (PRP) injections effectively treat hair loss and thinning in both men and women, with high satisfaction and no major side effects.

IFHUT shows better hair growth than FUE, but needs improvements in positioning, speed, and accuracy.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Dermoscopy is useful for identifying and tracking different types of hair loss without scarring.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.